Ori Alperovitz

Ori Alperovitz is the CEO of Cann10, a medical cannabis company based in Israel.12 He is an experienced entrepreneur and international executive manager with over 15 years of experience in multidisciplinary projects within the medical services field.2

Professional Background

Alperovitz has a diverse background in the healthcare industry:

• CEO at Cann10: He currently leads this medical cannabis company, which offers products, technologies, and operates the CannXL innovation center.12
• CEO at Sharap Plus: He has also served as the CEO of Sharapplus Ltd., a chain of private medical centers.2
• Founder and Consultant: Alperovitz has successful track records as a founder, CEO, and VP of Business Development for both established companies and startups.2

Expertise

Ori Alperovitz is known for his expertise in several areas:

• Founding and operating medical centers and specialized medical services globally
• Establishing international marketing and sales platforms for medical service companies
• Managing all aspects of medical services companies
• Business consulting and project management in the medical field2

Current Role at Cann10

As CEO of Cann10, Alperovitz has been involved in significant developments in the medical cannabis industry:

• He led Cann10's collaboration with Epigenetics to form Cann10 EpiGen, a venture aimed at developing genetically modified "mega-cannabis" using cutting-edge breeding technology.1
• Under his leadership, Cann10 is working on expanding its operations both in Israel and abroad, focusing on innovative cultivation technologies and promoting cannabis research and development.1

Ori Alperovitz's LinkedIn username is orialperovitz, as mentioned in the query.3